Latest news
Tenax shares nosedive as heart failure drug fails in Phase 3 - BioSpaceBioSpace · Mon, 10 Aug 2026 13:00:28 GMTTenax Therapeutics (NASDAQ:TENX) Drops 85% as Phase 3 LEVEL Study Fails to Meet Main Endpoints - TechStock²TechStock² · Mon, 10 Aug 2026 12:46:29 GMTHeart failure drug from Tenax Therapeutics fails in pivotal study - statnews.comstatnews.com · Mon, 10 Aug 2026 11:43:53 GMT